A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: DS-8201a
Sponsor: Daiichi Sankyo
Collaborators: AstraZeneca|Daiichi Sankyo Co., Ltd.